AFC-HD AMS Life Science Co., Ltd.

TSE:2927.T

835 (JPY) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2023202220212020201920182017201620152014201320122011201020092008
Revenue 25,579.00922,997.12722,368.07615,819.28116,252.88915,795.64315,141.75414,631.25614,415.22913,727.89614,366.17814,794.67414,653.83114,448.96312,813.39310,221.995
Cost of Revenue 16,256.13114,418.16415,503.06711,264.6811,732.03211,203.03910,533.96910,241.36910,154.3739,615.8589,929.88610,052.3829,266.4269,245.9197,897.286,107.288
Gross Profit 9,322.8788,578.9636,865.0094,554.6014,520.8574,592.6044,607.7854,389.8874,260.8564,112.0384,436.2924,742.2925,387.4055,203.0444,916.1134,114.707
Gross Profit Ratio 0.3640.3730.3070.2880.2780.2910.3040.30.2960.30.3090.3210.3680.360.3840.403
Reseach & Development Expenses 145.058153.029163.7166.359156.62139.187116.114110.1391081058200000
General & Administrative Expenses 6,633.4576,525.7953,913.8212,902.2772,876.9452,842.9132,882.4032,900.892,8462,9992,98200000
Selling & Marketing Expenses 74873650443850558653948742851750000000
SG&A 7,381.4577,261.7954,417.8213,340.2773,381.9453,428.9133,421.4033,387.893,2743,5163,48200000
Other Expenses 23.2287,567.8154,619.7683,460.9223,539.58512.63836.4640.19235.83353.91142.75105.05754.50292.6756.426103.922
Operating Expenses 7,686.5927,567.8154,619.7683,460.9223,539.5853,569.123,538.5373,499.0493,309.663,547.5113,534.1394,031.1024,362.7334,435.3184,178.4233,265.17
Operating Income 1,636.2851,385.7922,245.2391,093.679981.2711,023.4831,069.247890.838951.194564.527902.152711.1891,024.67767.724737.69849.536
Operating Income Ratio 0.0640.060.10.0690.060.0650.0710.0610.0660.0410.0630.0480.070.0530.0580.083
Total Other Income Expenses Net -90.316-150.353-87.432-89.336109.753-37.83-431.953-135.774.573-70.27574.615255.628-95.764-83.468-313.447-43.753
Income Before Tax 1,545.9691,235.4392,157.8071,004.3431,091.024985.653637.295755.068955.769494.252976.768966.818928.908684.258424.243805.784
Income Before Tax Ratio 0.060.0540.0960.0630.0670.0620.0420.0520.0660.0360.0680.0650.0630.0470.0330.079
Income Tax Expense 439.356497.922662.358327.659307.732248.972171.402269.185355.742211.273404.376397.773438.748489.216294.526450.96
Net Income 1,102.563735.3531,495.554676.683783.292736.68465.893489.6605.503282.979572.392569.044490.159195.042129.717354.824
Net Income Ratio 0.0430.0320.0670.0430.0480.0470.0310.0330.0420.0210.040.0380.0330.0130.010.035
EPS 78.5152.33107.1248.1255.758.2838.4840.4750.6423.8248.1447.7441.1316.3510.8229.55
EPS Diluted 78.4652.08106.348.1255.758.2838.4840.345023.4848.1447.7441.1216.3410.827.53
EBITDA 2,659.7972,392.4122,863.2781,638.3851,502.4751,462.3581,489.5181,287.791,426.8871,127.5211,543.0941,546.7181,443.6921,292.5211,185.121,232.414
EBITDA Ratio 0.1040.1040.1280.1040.0920.0930.0980.0880.0990.0820.1070.1050.0990.0890.0920.121